Merck & Co Inc (MRK)

MRK (NYSE:Drugs) EQUITY
$58.43
neg -0.17
-0.29%
Today's Range: 58.11 - 58.59 | MRK Avg Daily Volume: 8,771,700
Last Update: 07/28/16 - 4:00 PM EDT
Volume: 7,286,912
YTD Performance: 10.94%
Open: $58.51
Previous Close: $58.60
52 Week Range: $45.69 - $60.07
Oustanding Shares: 2,768,025,348
Market Cap: 161,541,959,309
6-Month Chart
TheStreet Ratings Grade for MRK
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 4 5 5 5
Moderate Buy 0 0 0 0
Hold 8 7 7 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.33 2.17 2.17 2.17
Latest Dividend: 0.46
Latest Dividend Yield: 3.15%
Dividend Ex-Date: 09/13/16
Price Earnings Ratio: 35.80
Price Earnings Comparisons:
MRK Sector Avg. S&P 500
35.80 36.00 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
4.07% 2.83% 20.85%
GROWTH 12 Mo 3 Yr CAGR
Revenue -6.50 -0.20 -0.06
Net Income -62.60 -0.30 -0.11
EPS -61.70 -0.20 -0.08
Earnings for MRK:
EBITDA 13.92B
Revenue 39.50B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $0.92 $0.98 $3.72 $3.71
Number of Analysts 9 5 10 10
High Estimate $0.94 $1.00 $3.77 $3.94
Low Estimate $0.90 $0.95 $3.67 $3.33
Prior Year $0.86 $0.96 $3.59 $3.72
Growth Rate (Year over Year) 6.72% 1.67% 3.62% -0.19%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
It's too cheap for a biotech giant with years of patent protection for its key products and great cash flow.
Bearish
Jul 18, 2016 | 7:45 AM EDT
MRK was downgraded from Outperform to Market Perform, BMO Capital said. Valuation call, based on a $62 price target.
Let me give you the unassailable themes.
I care about making and preserving my clients' money.
You have to be impressed by the breadth of XNCR's pipeline and significant partnerships with major players.
Both have good capital appreciation potential.
Both have good capital appreciation potential.
Financial engineering such as stock buybacks aren't the best buy for companies.

Columnist Conversations

From Real Money's Tony Owusu: Amazon (AMZN) continued its strong run of success Thursday afternoon following...
Markets mixed as we head to the last hour of trading.  Oil continues to fall and edgy closer and closer t...
Natural Gas has exploded to the upside today in reaction to a much less than expected build in inventories dur...
As I like to preach in our chat room and webinars, we are in the MOVING business, not the STORAGE business.&nb...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.